NCT00506051View on ClinicalTrials.gov

ZD6474(Vandetanib) + Alimta Combo Study

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

October 31, 2011

Conditions
CarcinomaNon-Small Cell LungLung Cancer
Interventions
DRUG

ZD6474 (vandetanib) 100mg

once daily oral tablet

DRUG

pemetrexed

intravenous infusion

DRUG

ZD6474 (vandetanib) 300mg

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00506051 - ZD6474(Vandetanib) + Alimta Combo Study | Biotech Hunter | Biotech Hunter